I commend the hon. Lady for bringing this forward. I declare an interest as a type 2 diabetic—a condition that is not as bad, I have to say, but still has to be managed. Northern Ireland has a high prevalence of diabetes, with almost 115,000 people living with the condition, and the number is increasing annually. Does the hon. Lady agree that early intervention for those who are pre-diabetic is essential and that consideration must be given to widening the ability for Ozempic, Mounjaro and other glucagon-like peptide-1 drugs to be prescribed more widely to help in the prevention of full-blown type 2 diabetes? That needs to be done not just in my constituency or the hon. Lady’s but across this great United Kingdom of Great Britain and Northern Ireland.